{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:09:39Z","timestamp":1789002579441,"version":"build-2803163510"},"reference-count":101,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T00:00:00Z","timestamp":1788998400000},"content-version":"vor","delay-in-days":77,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"PRIN-MIUR 2022","award":["2022ZFFALH"],"award-info":[{"award-number":["2022ZFFALH"]}]},{"name":"My First AIRC","award":["23099"],"award-info":[{"award-number":["23099"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Transl Med"],"DOI":"10.1186\/s12967-026-08446-x","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T08:35:35Z","timestamp":1782376535000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Single-cell profiling reveals a novel CAF subpopulation linking stromal heterogeneity to immune suppression in breast cancer subtypes"],"prefix":"10.1186","volume":"24","author":[{"given":"Virginia","family":"Vigiano Benedetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Santoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tancredi Massimo","family":"Pentimalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Bei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Cifaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Barillari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Spallotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Cencioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7118-5186","authenticated-orcid":false,"given":"Ombretta","family":"Melaiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"8446_CR1","doi-asserted-by":"publisher","first-page":"107753","DOI":"10.1016\/j.pharmthera.2020.107753","volume":"221","author":"Y Xiao","year":"2021","unstructured":"Xiao Y, Yu D. Tumor microenvironment as a therapeutic target in cancer. Pharmacol Ther. 2021;221:107753.","journal-title":"Pharmacol Ther"},{"issue":"5","key":"8446_CR2","doi-asserted-by":"publisher","first-page":"905","DOI":"10.1016\/j.ccell.2025.03.004","volume":"43","author":"Y Liu","year":"2025","unstructured":"Liu Y, Sinjab A, Min J, Han G, Paradiso F, Zhang Y, et al. Conserved spatial subtypes and cellular neighborhoods of cancer-associated fibroblasts revealed by single-cell spatial multi-omics. Cancer Cell. 2025;43(5):905\u2013e9246.","journal-title":"Cancer Cell"},{"issue":"1","key":"8446_CR3","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1186\/s13046-025-03527-z","volume":"44","author":"L Liu","year":"2025","unstructured":"Liu L, Wan W, Chang Y, Ao L, Xu Y, Xu X. Crosstalk between heterogeneous cancer-associated fibroblast subpopulations and the immune system in breast cancer: key players and promising therapeutic targets. J Exp Clin Cancer Res. 2025;44(1):263.","journal-title":"J Exp Clin Cancer Res"},{"issue":"4","key":"8446_CR4","doi-asserted-by":"publisher","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","volume":"31","author":"J Kim","year":"2025","unstructured":"Kim J, Harper A, McCormack V, Sung H, Houssami N, Morgan E, et al. Global patterns and trends in breast cancer incidence and mortality across 185 countries. Nat Med. 2025;31(4):1154\u201362.","journal-title":"Nat Med"},{"issue":"8","key":"8446_CR5","doi-asserted-by":"publisher","first-page":"554","DOI":"10.1038\/s41568-024-00714-6","volume":"24","author":"MA Harris","year":"2024","unstructured":"Harris MA, Savas P, Virassamy B, O\u2019Malley MMR, Kay J, Mueller SN, et al. Towards targeting the breast cancer immune microenvironment. Nat Rev Cancer. 2024;24(8):554\u201377.","journal-title":"Nat Rev Cancer"},{"issue":"1","key":"8446_CR6","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1038\/s41392-024-02108-4","volume":"10","author":"X Xiong","year":"2025","unstructured":"Xiong X, Zheng L-W, Ding Y, Chen Y-F, Cai Y-W, Wang L-P, et al. Breast cancer: pathogenesis and treatments. Signal Transduct Target Ther. 2025;10(1):49.","journal-title":"Signal Transduct Target Ther"},{"key":"8446_CR7","doi-asserted-by":"crossref","unstructured":"Orrantia-Borunda E, Anchondo-Nu\u00f1ez P, Acu\u00f1a-Aguilar LE, G\u00f3mez-Valles FO, Ram\u00edrez-Valdespino CA. Subtypes of Breast Cancer. 2022.","DOI":"10.36255\/exon-publications-breast-cancer-subtypes"},{"issue":"46","key":"8446_CR8","doi-asserted-by":"publisher","first-page":"20009","DOI":"10.1073\/pnas.1013805107","volume":"107","author":"Y Kojima","year":"2010","unstructured":"Kojima Y, Acar A, Eaton EN, Mellody KT, Scheel C, Ben-Porath I, et al. Autocrine TGF-beta and stromal cell-derived factor-1 (SDF-1) signaling drives the evolution of tumor-promoting mammary stromal myofibroblasts. Proc Natl Acad Sci U S A. 2010;107(46):20009\u201314.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"8446_CR9","doi-asserted-by":"publisher","first-page":"6838","DOI":"10.1038\/s41598-017-07144-5","volume":"7","author":"N Nair","year":"2017","unstructured":"Nair N, Calle AS, Zahra MH, Prieto-Vila M, Oo AKK, Hurley L, et al. A cancer stem cell model as the point of origin of cancer-associated fibroblasts in tumor microenvironment. Sci Rep. 2017;7(1):6838.","journal-title":"Sci Rep"},{"issue":"21","key":"8446_CR10","doi-asserted-by":"publisher","first-page":"10123","DOI":"10.1158\/0008-5472.CAN-07-3127","volume":"67","author":"EM Zeisberg","year":"2007","unstructured":"Zeisberg EM, Potenta S, Xie L, Zeisberg M, Kalluri R. Discovery of endothelial to mesenchymal transition as a source for carcinoma-associated fibroblasts. Cancer Res. 2007;67(21):10123\u20138.","journal-title":"Cancer Res"},{"issue":"3","key":"8446_CR11","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1016\/j.ccell.2018.01.011","volume":"33","author":"A Costa","year":"2018","unstructured":"Costa A, Kieffer Y, Scholer-Dahirel A, Pelon F, Bourachot B, Cardon M, et al. Fibroblast Heterogeneity and Immunosuppressive Environment in Human Breast Cancer. Cancer Cell. 2018;33(3):463\u2013e47910.","journal-title":"Cancer Cell"},{"issue":"1","key":"8446_CR12","doi-asserted-by":"publisher","first-page":"2806","DOI":"10.1038\/s41467-024-47068-z","volume":"15","author":"H Croizer","year":"2024","unstructured":"Croizer H, Mhaidly R, Kieffer Y, Gentric G, Djerroudi L, Leclere R, et al. Deciphering the spatial landscape and plasticity of immunosuppressive fibroblasts in breast cancer. Nat Commun. 2024;15(1):2806.","journal-title":"Nat Commun"},{"key":"8446_CR13","doi-asserted-by":"publisher","first-page":"23","DOI":"10.3390\/cancers13235878","volume":"13","author":"I Magagna","year":"2021","unstructured":"Magagna I, Gourdin N, Kieffer Y, Licaj M, Mhaidly R, Andre P, et al. CD73-Mediated Immunosuppression Is Linked to a Specific Fibroblast Population That Paves the Way for New Therapy in Breast Cancer. Cancers (Basel). 2021;13:23.","journal-title":"Cancers (Basel)"},{"issue":"5","key":"8446_CR14","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1038\/s41591-018-0014-x","volume":"24","author":"M Binnewies","year":"2018","unstructured":"Binnewies M, Roberts EW, Kersten K, Chan V, Fearon DF, Merad M, et al. Understanding the tumor immune microenvironment (TIME) for effective therapy. Nat Med. 2018;24(5):541\u201350.","journal-title":"Nat Med"},{"key":"8446_CR15","doi-asserted-by":"publisher","first-page":"414","DOI":"10.3389\/fimmu.2018.00414","volume":"9","author":"L Ziani","year":"2018","unstructured":"Ziani L, Chouaib S, Thiery J. Alteration of the Antitumor Immune Response by Cancer-Associated Fibroblasts. Front Immunol. 2018;9:414.","journal-title":"Front Immunol"},{"issue":"7","key":"8446_CR16","doi-asserted-by":"publisher","first-page":"459","DOI":"10.1038\/s41577-024-01050-4","volume":"24","author":"A Altieri","year":"2024","unstructured":"Altieri A, Buechler MB. Breast cancer-associated fibroblasts maintain self-renewing immunosuppressive macrophages. Nat Rev Immunol. 2024;24(7):459.","journal-title":"Nat Rev Immunol"},{"issue":"1","key":"8446_CR17","doi-asserted-by":"publisher","first-page":"948","DOI":"10.1038\/s41467-018-03347-0","volume":"9","author":"MA Lakins","year":"2018","unstructured":"Lakins MA, Ghorani E, Munir H, Martins CP, Shields JD. Cancer-associated fibroblasts induce antigen-specific deletion of CD8\u2009+\u2009T Cells to protect tumour cells. Nat Commun. 2018;9(1):948.","journal-title":"Nat Commun"},{"issue":"3","key":"8446_CR18","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1245\/s10434-023-14715-6","volume":"31","author":"HS Kim","year":"2024","unstructured":"Kim HS, Noh Y-K, Min K-W, Kim D-H, Kwon MJ, Pyo JS, et al. Cancer-Associated Fibroblasts Together with a Decline in CD8\u2009+\u2009T Cells Predict a Worse Prognosis for Breast Cancer Patients. Ann Surg Oncol. 2024;31(3):2114\u201326.","journal-title":"Ann Surg Oncol"},{"issue":"3","key":"8446_CR19","doi-asserted-by":"publisher","first-page":"2127","DOI":"10.1245\/s10434-023-14817-1","volume":"31","author":"HS Kim","year":"2024","unstructured":"Kim HS, Min K-W. ASO Author Reflections: Cancer-Associated Fibroblasts with Decreased CD8\u2009+\u2009T Cells are Associated with a Poor Prognosis in the Treatment of Breast Cancer Patients. Ann Surg Oncol. 2024;31(3):2127\u20138.","journal-title":"Ann Surg Oncol"},{"issue":"16","key":"8446_CR20","doi-asserted-by":"publisher","first-page":"2904","DOI":"10.1158\/0008-5472.CAN-21-4141","volume":"82","author":"L Jenkins","year":"2022","unstructured":"Jenkins L, Jungwirth U, Avgustinova A, Iravani M, Mills A, Haider S, et al. Cancer-Associated Fibroblasts Suppress CD8\u2009+\u2009T-cell Infiltration and Confer Resistance to Immune-Checkpoint Blockade. Cancer Res. 2022;82(16):2904\u201317.","journal-title":"Cancer Res"},{"issue":"1","key":"8446_CR21","doi-asserted-by":"publisher","first-page":"2020984","DOI":"10.1080\/2162402X.2021.2020984","volume":"11","author":"S Zheng","year":"2022","unstructured":"Zheng S, Zou Y, Tang Y, Yang A, Liang J-Y, Wu L, et al. Landscape of cancer-associated fibroblasts identifies the secreted biglycan as a protumor and immunosuppressive factor in triple-negative breast cancer. Oncoimmunology. 2022;11(1):2020984.","journal-title":"Oncoimmunology"},{"key":"8446_CR22","doi-asserted-by":"publisher","first-page":"102843","DOI":"10.1016\/j.ctrv.2024.102843","volume":"131","author":"S Ielpo","year":"2024","unstructured":"Ielpo S, Barberini F, Dabbagh Moghaddam F, Pesce S, Cencioni C, Spallotta F, et al. Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapy. Cancer Treat Rev. 2024;131:102843.","journal-title":"Cancer Treat Rev"},{"issue":"2","key":"8446_CR23","doi-asserted-by":"publisher","first-page":"189291","DOI":"10.1016\/j.bbcan.2025.189291","volume":"1880","author":"J Yang","year":"2025","unstructured":"Yang J, Xin B, Wang X, Wan Y. Cancer-associated fibroblasts in breast cancer in the single-cell era: Opportunities and challenges. Biochim Biophys acta Rev cancer. 2025;1880(2):189291.","journal-title":"Biochim Biophys acta Rev cancer"},{"issue":"1","key":"8446_CR24","doi-asserted-by":"publisher","first-page":"344","DOI":"10.1186\/s12967-025-06376-8","volume":"23","author":"X Zhang","year":"2025","unstructured":"Zhang X, Ren B, Liu B, Wang R, Li S, Zhao Y, et al. Single-cell RNA sequencing and spatial transcriptomics reveal the heterogeneity and intercellular communication of cancer-associated fibroblasts in gastric cancer. J Transl Med. 2025;23(1):344.","journal-title":"J Transl Med"},{"issue":"1","key":"8446_CR25","doi-asserted-by":"publisher","first-page":"198","DOI":"10.1186\/s12967-025-06192-0","volume":"23","author":"Y Liu","year":"2025","unstructured":"Liu Y, Dong G, Yu J, Liang P. Integration of single-cell and spatial transcriptomics reveals fibroblast subtypes in hepatocellular carcinoma: spatial distribution, differentiation trajectories, and therapeutic potential. J Transl Med. 2025;23(1):198.","journal-title":"J Transl Med"},{"issue":"9","key":"8446_CR26","doi-asserted-by":"publisher","first-page":"1330","DOI":"10.1158\/2159-8290.CD-19-1384","volume":"10","author":"Y Kieffer","year":"2020","unstructured":"Kieffer Y, Hocine HR, Gentric G, Pelon F, Bernard C, Bourachot B, et al. Single-Cell Analysis Reveals Fibroblast Clusters Linked to Immunotherapy Resistance in Cancer. Cancer Discov. 2020;10(9):1330\u201351.","journal-title":"Cancer Discov"},{"issue":"11","key":"8446_CR27","doi-asserted-by":"publisher","first-page":"e107333","DOI":"10.15252\/embj.2020107333","volume":"40","author":"B Pal","year":"2021","unstructured":"Pal B, Chen Y, Vaillant F, Capaldo BD, Joyce R, Song X, et al. A single-cell RNA expression atlas of normal, preneoplastic and tumorigenic states in the human breast. EMBO J. 2021;40(11):e107333.","journal-title":"EMBO J"},{"issue":"9","key":"8446_CR28","doi-asserted-by":"publisher","first-page":"1334","DOI":"10.1038\/s41588-021-00911-1","volume":"53","author":"SZ Wu","year":"2021","unstructured":"Wu SZ, Al-Eryani G, Roden DL, Junankar S, Harvey K, Andersson A, et al. A single-cell and spatially resolved atlas of human breast cancers. Nat Genet. 2021;53(9):1334\u201347.","journal-title":"Nat Genet"},{"issue":"5","key":"8446_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/s41591-021-01323-8","volume":"27","author":"A Bassez","year":"2021","unstructured":"Bassez A, Vos H, Van Dyck L, Floris G, Arijs I, Desmedt C, et al. A single-cell map of intratumoral changes during anti-PD1 treatment of patients with breast cancer. Nat Med. 2021;27(5):820\u201332.","journal-title":"Nat Med"},{"issue":"1","key":"8446_CR30","doi-asserted-by":"publisher","first-page":"10232","DOI":"10.1038\/s41467-024-54145-w","volume":"15","author":"X Wang","year":"2024","unstructured":"Wang X, Venet D, Lifrange F, Larsimont D, Rediti M, Stenbeck L, et al. Spatial transcriptomics reveals substantial heterogeneity in triple-negative breast cancer with potential clinical implications. Nat Commun. 2024;15(1):10232.","journal-title":"Nat Commun"},{"issue":"8","key":"8446_CR31","doi-asserted-by":"publisher","first-page":"1160","DOI":"10.1200\/JCO.2008.18.1370","volume":"27","author":"JS Parker","year":"2009","unstructured":"Parker JS, Mullins M, Cheang MCU, Leung S, Voduc D, Vickery T, et al. Supervised risk predictor of breast cancer based on intrinsic subtypes. J Clin Oncol. 2009;27(8):1160\u20137.","journal-title":"J Clin Oncol"},{"key":"8446_CR32","doi-asserted-by":"crossref","unstructured":"Grimaldi AM, Conte F, Pane K, Fiscon G, Mirabelli P, Baselice S, et al. The new paradigm of network medicine to analyze breast cancer phenotypes. Int J Mol Sci. 2020;21(18).","DOI":"10.3390\/ijms21186690"},{"issue":"4","key":"8446_CR33","doi-asserted-by":"publisher","first-page":"782","DOI":"10.1016\/j.immuni.2013.10.003","volume":"39","author":"G Bindea","year":"2013","unstructured":"Bindea G, Mlecnik B, Tosolini M, Kirilovsky A, Waldner M, Obenauf AC, et al. Spatiotemporal dynamics of intratumoral immune cells reveal the immune landscape in human cancer. Immunity. 2013;39(4):782\u201395.","journal-title":"Immunity"},{"issue":"17","key":"8446_CR34","doi-asserted-by":"publisher","first-page":"4175","DOI":"10.1158\/1078-0432.CCR-17-1846","volume":"24","author":"K Woroniecka","year":"2018","unstructured":"Woroniecka K, Chongsathidkiet P, Rhodin K, Kemeny H, Dechant C, Farber SH, et al. T-Cell Exhaustion Signatures Vary with Tumor Type and Are Severe in Glioblastoma. Clin Cancer Res. 2018;24(17):4175\u201386.","journal-title":"Clin Cancer Res"},{"issue":"6","key":"8446_CR35","doi-asserted-by":"publisher","first-page":"848","DOI":"10.1038\/s41590-022-01224-z","volume":"23","author":"JA Belk","year":"2022","unstructured":"Belk JA, Daniel B, Satpathy AT. Epigenetic regulation of T cell exhaustion. Nat Immunol. 2022;23(6):848\u201360.","journal-title":"Nat Immunol"},{"issue":"23","key":"8446_CR36","doi-asserted-by":"publisher","first-page":"5734","DOI":"10.1111\/bph.70215","volume":"182","author":"M Posta","year":"2025","unstructured":"Posta M, Gy\u0151rffy B. Pathway-level mutational signatures predict breast cancer outcomes and reveal therapeutic targets. Br J Pharmacol. 2025;182(23):5734\u201347.","journal-title":"Br J Pharmacol"},{"issue":"7403","key":"8446_CR37","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature10983","volume":"486","author":"C Curtis","year":"2012","unstructured":"Curtis C, Shah SP, Chin S-F, Turashvili G, Rueda OM, Dunning MJ, et al. The genomic and transcriptomic architecture of 2,000 breast tumours reveals novel subgroups. Nature. 2012;486(7403):346\u201352.","journal-title":"Nature"},{"key":"8446_CR38","doi-asserted-by":"publisher","first-page":"11479","DOI":"10.1038\/ncomms11479","volume":"7","author":"B Pereira","year":"2016","unstructured":"Pereira B, Chin S-F, Rueda OM, Vollan H-KM, Provenzano E, Bardwell HA, et al. The somatic mutation profiles of 2,433 breast cancers refines their genomic and transcriptomic landscapes. Nat Commun. 2016;7:11479.","journal-title":"Nat Commun"},{"issue":"4","key":"8446_CR39","doi-asserted-by":"publisher","first-page":"721","DOI":"10.1093\/jamia\/ocw022","volume":"23","author":"J Hintzsche","year":"2016","unstructured":"Hintzsche J, Kim J, Yadav V, Amato C, Robinson SE, Seelenfreund E, et al. IMPACT: a whole-exome sequencing analysis pipeline for integrating molecular profiles with actionable therapeutics in clinical samples. J Am Med Inf Assoc. 2016;23(4):721\u201330.","journal-title":"J Am Med Inf Assoc"},{"issue":"12","key":"8446_CR40","doi-asserted-by":"publisher","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","volume":"48","author":"P Peduzzi","year":"1995","unstructured":"Peduzzi P, Concato J, Feinstein AR, Holford TR. Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates. J Clin Epidemiol. 1995;48(12):1503\u201310.","journal-title":"J Clin Epidemiol"},{"issue":"4","key":"8446_CR41","doi-asserted-by":"publisher","first-page":"361","DOI":"10.1002\/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4","volume":"15","author":"FE Harrell","year":"1996","unstructured":"Harrell FE, Lee KL, Mark DB. Multivariable prognostic models: issues in developing models, evaluating assumptions and adequacy, and measuring and reducing errors. Stat Med. 1996;15(4):361\u201387.","journal-title":"Stat Med"},{"issue":"1","key":"8446_CR42","doi-asserted-by":"publisher","first-page":"380","DOI":"10.1038\/s41467-018-08023-x","volume":"10","author":"X Wang","year":"2019","unstructured":"Wang X, Park J, Susztak K, Zhang NR, Li M. Bulk tissue cell type deconvolution with multi-subject single-cell expression reference. Nat Commun. 2019;10(1):380.","journal-title":"Nat Commun"},{"issue":"11","key":"8446_CR43","doi-asserted-by":"publisher","first-page":"3140","DOI":"10.1002\/ijc.32369","volume":"145","author":"JT Fekete","year":"2019","unstructured":"Fekete JT, Gy\u0151rffy B. ROCplot.org: Validating predictive biomarkers of chemotherapy\/hormonal therapy\/anti-HER2 therapy using transcriptomic data of 3,104 breast cancer patients. Int J cancer. 2019;145(11):3140\u201351.","journal-title":"Int J cancer"},{"issue":"3","key":"8446_CR44","first-page":"228","volume":"2","author":"Z Mih\u00e1ly","year":"2013","unstructured":"Mih\u00e1ly Z, Gy\u0151rffy B. Improving Pathological Assessment of Breast Cancer by Employing Array-Based Transcriptome Analysis. Microarrays (Basel Switzerland). 2013;2(3):228\u201342.","journal-title":"Microarrays (Basel Switzerland)"},{"issue":"1","key":"8446_CR45","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1186\/s43556-024-00233-8","volume":"5","author":"K Lv","year":"2024","unstructured":"Lv K, He T. Cancer-associated fibroblasts: heterogeneity, tumorigenicity and therapeutic targets. Mol Biomed. 2024;5(1):70.","journal-title":"Mol Biomed"},{"issue":"8","key":"8446_CR46","doi-asserted-by":"publisher","first-page":"1708","DOI":"10.1016\/j.cell.2023.01.040","volume":"186","author":"E Nolan","year":"2023","unstructured":"Nolan E, Lindeman GJ, Visvader JE. Deciphering breast cancer: from biology to the clinic. Cell. 2023;186(8):1708\u201328.","journal-title":"Cell"},{"key":"8446_CR47","doi-asserted-by":"publisher","first-page":"106","DOI":"10.3389\/fonc.2018.00106","volume":"8","author":"I Tirado-Hurtado","year":"2018","unstructured":"Tirado-Hurtado I, Fajardo W, Pinto JA. DNA Damage Inducible Transcript 4 Gene: The Switch of the Metabolism as Potential Target in Cancer. Front Oncol. 2018;8:106.","journal-title":"Front Oncol"},{"issue":"1","key":"8446_CR48","doi-asserted-by":"publisher","first-page":"82","DOI":"10.1186\/s12894-018-0388-6","volume":"18","author":"J Ye","year":"2018","unstructured":"Ye J, Zhang Y, Cai Z, Jiang M, Li B, Chen G, et al. Increased expression of immediate early response gene 3 protein promotes aggressive progression and predicts poor prognosis in human bladder cancer. BMC Urol. 2018;18(1):82.","journal-title":"BMC Urol"},{"issue":"9","key":"8446_CR49","doi-asserted-by":"publisher","first-page":"2094","DOI":"10.1016\/j.bbadis.2019.04.007","volume":"1865","author":"AM Merlot","year":"2019","unstructured":"Merlot AM, Porter GM, Sahni S, Lim EG, Peres P, Richardson DR. The metastasis suppressor, NDRG1, differentially modulates the endoplasmic reticulum stress response. Biochim Biophys acta Mol basis Dis. 2019;1865(9):2094\u2013110.","journal-title":"Biochim Biophys acta Mol basis Dis"},{"key":"8446_CR50","doi-asserted-by":"publisher","first-page":"100107","DOI":"10.1016\/j.adcanc.2023.100107","volume":"8","author":"I Gupta","year":"2023","unstructured":"Gupta I, Hussein O, Sastry KS, Bougarn S, Gopinath N, Chin-Smith E, et al. Deciphering the complexities of cancer cell immune evasion: Mechanisms and therapeutic implications. Adv Cancer Biol - Metastasis. 2023;8:100107.","journal-title":"Adv Cancer Biol - Metastasis"},{"issue":"1","key":"8446_CR51","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1186\/s12943-025-02533-1","volume":"25","author":"Z Huang","year":"2025","unstructured":"Huang Z, Chen J, Zhu T, Li J, Ng HY, Zhou Y, et al. Cancer-associated fibroblasts in the tumor microenvironment: heterogeneity, crosstalk mechanisms, and therapeutic implications. Mol Cancer. 2025;25(1):19.","journal-title":"Mol Cancer"},{"issue":"1","key":"8446_CR52","doi-asserted-by":"publisher","first-page":"4294","DOI":"10.1038\/s41467-023-39762-1","volume":"14","author":"L Cords","year":"2023","unstructured":"Cords L, Tietscher S, Anzeneder T, Langwieder C, Rees M, de Souza N, et al. Cancer-associated fibroblast classification in single-cell and spatial proteomics data. Nat Commun. 2023;14(1):4294.","journal-title":"Nat Commun"},{"issue":"21","key":"8446_CR53","doi-asserted-by":"publisher","first-page":"12674","DOI":"10.18632\/aging.205205","volume":"15","author":"X Wu","year":"2023","unstructured":"Wu X, Lu W, Zhang W, Zhang D, Mei H, Zhang M, et al. Integrated analysis of single-cell RNA-seq and bulk RNA-seq unravels the heterogeneity of cancer-associated fibroblasts in TNBC. Aging. 2023;15(21):12674\u201397.","journal-title":"Aging"},{"issue":"7","key":"8446_CR54","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/s43018-020-0082-y","volume":"1","author":"G Friedman","year":"2020","unstructured":"Friedman G, Levi-Galibov O, David E, Bornstein C, Giladi A, Dadiani M, et al. Cancer-associated fibroblast compositions change with breast cancer progression linking the ratio of S100A4\u2009+\u2009and PDPN+ CAFs to clinical outcome. Nat cancer. 2020;1(7):692\u2013708.","journal-title":"Nat cancer"},{"issue":"3","key":"8446_CR55","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1084\/jem.20162024","volume":"214","author":"D \u00d6hlund","year":"2017","unstructured":"\u00d6hlund D, Handly-Santana A, Biffi G, Elyada E, Almeida AS, Ponz-Sarvise M, et al. Distinct populations of inflammatory fibroblasts and myofibroblasts in pancreatic cancer. J Exp Med. 2017;214(3):579\u201396.","journal-title":"J Exp Med"},{"issue":"8","key":"8446_CR56","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1158\/2159-8290.CD-19-0094","volume":"9","author":"E Elyada","year":"2019","unstructured":"Elyada E, Bolisetty M, Laise P, Flynn WF, Courtois ET, Burkhart RA, et al. Cross-Species Single-Cell Analysis of Pancreatic Ductal Adenocarcinoma Reveals Antigen-Presenting Cancer-Associated Fibroblasts. Cancer Discov. 2019;9(8):1102\u201323.","journal-title":"Cancer Discov"},{"issue":"1","key":"8446_CR57","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1038\/s41421-021-00271-4","volume":"7","author":"Y Wang","year":"2021","unstructured":"Wang Y, Liang Y, Xu H, Zhang X, Mao T, Cui J, et al. Single-cell analysis of pancreatic ductal adenocarcinoma identifies a novel fibroblast subtype associated with poor prognosis but better immunotherapy response. Cell Discov. 2021;7(1):36.","journal-title":"Cell Discov"},{"issue":"1","key":"8446_CR58","doi-asserted-by":"publisher","first-page":"2498","DOI":"10.1038\/s41467-024-46504-4","volume":"15","author":"MT Broz","year":"2024","unstructured":"Broz MT, Ko EY, Ishaya K, Xiao J, De Simone M, Hoi XP, et al. Metabolic targeting of cancer associated fibroblasts overcomes T-cell exclusion and chemoresistance in soft-tissue sarcomas. Nat Commun. 2024;15(1):2498.","journal-title":"Nat Commun"},{"issue":"11","key":"8446_CR59","doi-asserted-by":"publisher","first-page":"e70415","DOI":"10.1002\/mco2.70415","volume":"6","author":"C Fan","year":"2025","unstructured":"Fan C, Zhu W, Chen Y, Zhu W, Ding J. Cancer-Associated Fibroblasts: Origin, Classification, Tumorigenicity, and Targeting for Cancer Therapy. MedComm. 2025;6(11):e70415.","journal-title":"MedComm"},{"issue":"19","key":"8446_CR60","doi-asserted-by":"publisher","first-page":"3681","DOI":"10.1038\/s41388-019-0688-7","volume":"38","author":"G Comito","year":"2019","unstructured":"Comito G, Iscaro A, Bacci M, Morandi A, Ippolito L, Parri M, et al. Lactate modulates CD4\u2009+\u2009T-cell polarization and induces an immunosuppressive environment, which sustains prostate carcinoma progression via TLR8\/miR21 axis. Oncogene. 2019;38(19):3681\u201395.","journal-title":"Oncogene"},{"key":"8446_CR61","doi-asserted-by":"crossref","unstructured":"Ielpo S, Barberini F, Gaiba A, Baronti C, Greppi M, Obino V, et al. Lactate-mediated NK cell dysfunction as a prognostic marker and therapeutic target in breast cancer. Cell death Discov. 2026;12(1).","DOI":"10.1038\/s41420-026-03063-5"},{"issue":"3","key":"8446_CR62","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1007\/s00018-022-04199-0","volume":"79","author":"M Migault","year":"2022","unstructured":"Migault M, Sapkota S, Bracken CP. Transcriptional and post-transcriptional control of epithelial-mesenchymal plasticity: why so many regulators? Cell Mol Life Sci. 2022;79(3):182.","journal-title":"Cell Mol Life Sci"},{"key":"8446_CR63","doi-asserted-by":"publisher","first-page":"250435","DOI":"10.1155\/2013\/250435","volume":"2013","author":"GBRF da Silva","year":"2013","unstructured":"da Silva GBRF, Silva TGA, Duarte RA, Neto NL, Carrara HHA, Donadi EA, et al. Expression of the Classical and Nonclassical HLA Molecules in Breast Cancer. Int J Breast Cancer. 2013;2013:250435.","journal-title":"Int J Breast Cancer"},{"key":"8446_CR64","doi-asserted-by":"publisher","first-page":"70","DOI":"10.1016\/j.jconrel.2020.07.043","volume":"327","author":"F Combes","year":"2020","unstructured":"Combes F, Meyer E, Sanders NN. Immune cells as tumor drug delivery vehicles. J Control Release. 2020;327:70\u201387.","journal-title":"J Control Release"},{"issue":"11","key":"8446_CR65","doi-asserted-by":"publisher","first-page":"719","DOI":"10.1038\/nri3754","volume":"14","author":"T Kambayashi","year":"2014","unstructured":"Kambayashi T, Laufer TM. Atypical MHC class II-expressing antigen-presenting cells: can anything replace a dendritic cell? Nat Rev Immunol. 2014;14(11):719\u201330.","journal-title":"Nat Rev Immunol"},{"key":"8446_CR66","doi-asserted-by":"crossref","unstructured":"Kerdidani D, Aerakis E, Verrou KM, Angelidis I, Douka K, Maniou MA, et al. Lung tumor MHCII immunity depends on in situ antigen presentation by fibroblasts. J Exp Med. 2022;219(2).","DOI":"10.1084\/jem.20210815"},{"issue":"5","key":"8446_CR67","doi-asserted-by":"publisher","first-page":"1118","DOI":"10.1016\/j.jhep.2020.05.039","volume":"73","author":"M Zhang","year":"2020","unstructured":"Zhang M, Yang H, Wan L, Wang Z, Wang H, Ge C, et al. Single-cell transcriptomic architecture and intercellular crosstalk of human intrahepatic cholangiocarcinoma. J Hepatol. 2020;73(5):1118\u201330.","journal-title":"J Hepatol"},{"key":"8446_CR68","doi-asserted-by":"crossref","unstructured":"Harryvan TJ, Visser M, de Bruin L, Plug L, Griffioen L, Mulder A, et al. Enhanced antigen cross-presentation in human colorectal cancer-associated fibroblasts through upregulation of the lysosomal protease cathepsin S. J Immunother Cancer. 2022;10(3).","DOI":"10.1136\/jitc-2021-003591"},{"key":"8446_CR69","doi-asserted-by":"publisher","first-page":"1095839","DOI":"10.3389\/fgene.2022.1095839","volume":"13","author":"S Loizides","year":"2022","unstructured":"Loizides S, Constantinidou A. Triple negative breast cancer: Immunogenicity, tumor microenvironment, and immunotherapy. Front Genet. 2022;13:1095839.","journal-title":"Front Genet"},{"key":"8446_CR70","doi-asserted-by":"publisher","first-page":"1067463","DOI":"10.3389\/fimmu.2022.1067463","volume":"13","author":"V Karnaukhov","year":"2022","unstructured":"Karnaukhov V, Paes W, Woodhouse IB, Partridge T, Nicastri A, Brackenridge S, et al. HLA variants have different preferences to present proteins with specific molecular functions which are complemented in frequent haplotypes. Front Immunol. 2022;13:1067463.","journal-title":"Front Immunol"},{"issue":"2","key":"8446_CR71","doi-asserted-by":"publisher","first-page":"54","DOI":"10.3892\/ol.2023.14187","volume":"27","author":"D Meng","year":"2024","unstructured":"Meng D, Dong H, Wang C, Zang R, Wang J. Role of interleukin\u201332 in cancer progression (Review). Oncol Lett. 2024;27(2):54.","journal-title":"Oncol Lett"},{"issue":"2","key":"8446_CR72","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jdermsci.2020.09.003","volume":"100","author":"H Jia","year":"2020","unstructured":"Jia H, Mo W, Hong M, Jiang S, Zhang Y-Y, He D, et al. Interferon-\u03b1 inducible protein 6 (IFI6) confers protection against ionizing radiation in skin cells. J Dermatol Sci. 2020;100(2):139\u201347.","journal-title":"J Dermatol Sci"},{"issue":"1","key":"8446_CR73","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1186\/s13046-021-01954-2","volume":"40","author":"Q Chen","year":"2021","unstructured":"Chen Q, Jin J, Huang X, Wu F, Huang H, Zhan R. EMP3 mediates glioblastoma-associated macrophage infiltration to drive T cell exclusion. J Exp Clin Cancer Res. 2021;40(1):160.","journal-title":"J Exp Clin Cancer Res"},{"key":"8446_CR74","doi-asserted-by":"publisher","first-page":"704853","DOI":"10.3389\/fcell.2021.704853","volume":"9","author":"L Han","year":"2021","unstructured":"Han L, Chen S, Chen Z, Zhou B, Zheng Y, Shen L. Interleukin 32 Promotes Foxp3\u2009+\u2009Treg Cell Development and CD8\u2009+\u2009T Cell Function in Human Esophageal Squamous Cell Carcinoma Microenvironment. Front cell Dev Biol. 2021;9:704853.","journal-title":"Front cell Dev Biol"},{"issue":"2","key":"8446_CR75","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1080\/14789450.2018.1421071","volume":"15","author":"C Mueller","year":"2018","unstructured":"Mueller C, Haymond A, Davis JB, Williams A, Espina V. Protein biomarkers for subtyping breast cancer and implications for future research. Expert Rev Proteom. 2018;15(2):131\u201352.","journal-title":"Expert Rev Proteom"},{"key":"8446_CR76","doi-asserted-by":"crossref","unstructured":"Cocco S, Piezzo M, Calabrese A, Cianniello D, Caputo R, Lauro V Di, et al. Biomarkers in triple-negative breast cancer: state-of-the-art and future perspectives. Int J Mol Sci. 2020;21(13).","DOI":"10.3390\/ijms21134579"},{"key":"8446_CR77","doi-asserted-by":"publisher","first-page":"106535","DOI":"10.1016\/j.intimp.2020.106535","volume":"84","author":"K Barzaman","year":"2020","unstructured":"Barzaman K, Karami J, Zarei Z, Hosseinzadeh A, Kazemi MH, Moradi-Kalbolandi S, et al. Breast cancer: Biology, biomarkers, and treatments. Int Immunopharmacol. 2020;84:106535.","journal-title":"Int Immunopharmacol"},{"issue":"10","key":"8446_CR78","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.7150\/thno.11543","volume":"5","author":"G Bertoli","year":"2015","unstructured":"Bertoli G, Cava C, Castiglioni I, MicroRNAs. New Biomarkers for Diagnosis, Prognosis, Therapy Prediction and Therapeutic Tools for Breast Cancer. Theranostics. 2015;5(10):1122\u201343.","journal-title":"Theranostics"},{"issue":"1","key":"8446_CR79","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1159\/000489954","volume":"47","author":"W-J Zeng","year":"2018","unstructured":"Zeng W-J, Yang Y-L, Liu Z-Z, Wen Z-P, Chen Y-H, Hu X-L, et al. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas. Cell Physiol Biochem. 2018;47(1):428\u201339.","journal-title":"Cell Physiol Biochem"},{"key":"8446_CR80","doi-asserted-by":"publisher","first-page":"977251","DOI":"10.3389\/fonc.2022.977251","volume":"12","author":"J Dong","year":"2022","unstructured":"Dong J, Wang F, Gao X, Zhao H, Zhang J, Wang N, et al. Integrated analysis of genome-wide DNA methylation and cancer-associated fibroblasts identified prognostic biomarkers and immune checkpoint blockade in lower grade gliomas. Front Oncol. 2022;12:977251.","journal-title":"Front Oncol"},{"issue":"3","key":"8446_CR81","doi-asserted-by":"publisher","first-page":"1148","DOI":"10.3390\/ijms27031148","volume":"27","author":"S Pomella","year":"2026","unstructured":"Pomella S, Bei R, Melaiu O, Barillari G. Fibronectin Is a Likely Therapeutic Target Shared by Oral and Breast Carcinomas. Int J Mol Sci. 2026;27(3):1148.","journal-title":"Int J Mol Sci"},{"key":"8446_CR82","doi-asserted-by":"publisher","first-page":"913659","DOI":"10.3389\/fgene.2022.913659","volume":"13","author":"X-X Zhang","year":"2022","unstructured":"Zhang X-X, Luo J-H, Wu L-Q. FN1 overexpression is correlated with unfavorable prognosis and immune infiltrates in breast cancer. Front Genet. 2022;13:913659.","journal-title":"Front Genet"},{"issue":"1","key":"8446_CR83","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12672-024-01107-9","volume":"15","author":"C Ye","year":"2024","unstructured":"Ye C, Jiang S, Zeng T, He S, Cao J, Xiao J. The role of LOXL2 in tumor progression, immune response and cellular senescence: a comprehensive analysis. Discov Oncol. 2024;15(1):245.","journal-title":"Discov Oncol"},{"key":"8446_CR84","doi-asserted-by":"crossref","unstructured":"Ferreira S, Saraiva N, Rijo P, Fernandes AS. LOXL2 inhibitors and breast cancer progression. Antioxid (Basel Switzerland). 2021;10(2).","DOI":"10.3390\/antiox10020312"},{"key":"8446_CR85","doi-asserted-by":"publisher","first-page":"883998","DOI":"10.3389\/fphar.2022.883998","volume":"13","author":"S Ramos","year":"2022","unstructured":"Ramos S, Ferreira S, Fernandes AS, Saraiva N. Lysyl Oxidases Expression and Breast Cancer Progression: A Bioinformatic Analysis. Front Pharmacol. 2022;13:883998.","journal-title":"Front Pharmacol"},{"issue":"13","key":"8446_CR86","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2217\/bmm-2020-0323","volume":"15","author":"M Li","year":"2021","unstructured":"Li M, Wang Q, Zheng Q, Wu L, Zhao B, Wu Y. Prognostic and diagnostic roles of prolyl 4-hydroxylase subunit \u03b1 members in breast cancer. Biomark Med. 2021;15(13):1085\u201395.","journal-title":"Biomark Med"},{"key":"8446_CR87","doi-asserted-by":"crossref","unstructured":"Aggarwal V, Sahoo S, Donnenberg VS, Chakraborty P, Jolly MK, Sant S. P4HA2: a link between tumor-intrinsic hypoxia, partial EMT and collective migration. Adv Cancer Biol - Metastasis. 2022;5.","DOI":"10.1016\/j.adcanc.2022.100057"},{"issue":"1","key":"8446_CR88","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1186\/s12943-025-02490-9","volume":"24","author":"B Chen","year":"2025","unstructured":"Chen B, Tang H, Zheng X, Xie F, Yu P, Lyu Y, et al. Spatial and functional dissection of cancer-associated fibroblasts-mediated immune modulation in H. pylori-associated gastric cancer. Mol Cancer. 2025;24(1):282.","journal-title":"Mol Cancer"},{"issue":"1","key":"8446_CR89","doi-asserted-by":"publisher","first-page":"30","DOI":"10.1186\/s12943-016-0515-5","volume":"15","author":"G Cheng","year":"2016","unstructured":"Cheng G, Fan X, Hao M, Wang J, Zhou X, Sun X. Higher levels of TIMP-1 expression are associated with a poor prognosis in triple-negative breast cancer. Mol Cancer. 2016;15(1):30.","journal-title":"Mol Cancer"},{"issue":"1","key":"8446_CR90","first-page":"105","volume":"10","author":"S Aliwaini","year":"2019","unstructured":"Aliwaini S, Lubbad AM, Shourfa A, Hamada HAA, Ayesh B, Abu Tayem HEM, et al. Overexpression of TBX3 transcription factor as a potential diagnostic marker for breast cancer. Mol Clin Oncol. 2019;10(1):105\u201312.","journal-title":"Mol Clin Oncol"},{"issue":"6","key":"8446_CR91","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1038\/s41419-021-03797-3","volume":"12","author":"J Ma","year":"2021","unstructured":"Ma J, He Z, Zhang H, Zhang W, Gao S, Ni X. SEC61G promotes breast cancer development and metastasis via modulating glycolysis and is transcriptionally regulated by E2F1. Cell Death Dis. 2021;12(6):550.","journal-title":"Cell Death Dis"},{"issue":"1","key":"8446_CR92","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1186\/s12905-025-04039-w","volume":"25","author":"JQ Xia","year":"2025","unstructured":"Xia JQ, Wang YL, Li XL, Wang JN, Li FC, Jia SY, et al. Lactate dehydrogenase a is a crucial biomarker that affects the prognosis, chemotherapy effect, and immune infiltration of breast cancer. BMC Womens Health. 2025;25(1):497.","journal-title":"BMC Womens Health"},{"issue":"3","key":"8446_CR93","first-page":"773","volume":"12","author":"L-L Liu","year":"2020","unstructured":"Liu L-L, Chen S-L, Huang Y-H, Yang X, Wang C-H, He J-H, et al. Adrenomedullin inhibits tumor metastasis and is associated with good prognosis in triple-negative breast cancer patients. Am J Transl Res. 2020;12(3):773\u201386.","journal-title":"Am J Transl Res"},{"key":"8446_CR94","doi-asserted-by":"publisher","first-page":"40524","DOI":"10.1038\/srep40524","volume":"7","author":"Y Zhang","year":"2017","unstructured":"Zhang Y, Xu Y, Ma J, Pang X, Dong M. Adrenomedullin promotes angiogenesis in epithelial ovarian cancer through upregulating hypoxia-inducible factor-1\u03b1 and vascular endothelial growth factor. Sci Rep. 2017;7:40524.","journal-title":"Sci Rep"},{"issue":"1","key":"8446_CR95","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s40364-024-00662-1","volume":"12","author":"H Xu","year":"2024","unstructured":"Xu H, Chai H, Chen M, Zhu R, Jiang S, Liu X, et al. Single-cell RNA sequencing identifies a subtype of FN1\u2009+\u2009tumor-associated macrophages associated with glioma recurrence and as a biomarker for immunotherapy. Biomark Res. 2024;12(1):114.","journal-title":"Biomark Res"},{"issue":"5","key":"8446_CR96","first-page":"1641","volume":"43","author":"Z Fan","year":"2020","unstructured":"Fan Z, Zheng W, Li H, Wu W, Liu X, Sun Z, et al. LOXL2 upregulates hypoxia\u2013inducible factor\u20131\u03b1 signaling through Snail\u2013FBP1 axis in hepatocellular carcinoma cells. Oncol Rep. 2020;43(5):1641\u20139.","journal-title":"Oncol Rep"},{"issue":"12","key":"8446_CR97","doi-asserted-by":"publisher","first-page":"R1369","DOI":"10.1152\/ajpregu.00349.2014","volume":"307","author":"MC Manresa","year":"2014","unstructured":"Manresa MC, Godson C, Taylor CT. Hypoxia-sensitive pathways in inflammation-driven fibrosis. Am J Physiol Regul Integr Comp Physiol. 2014;307(12):R1369\u201380.","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"issue":"17","key":"8446_CR98","doi-asserted-by":"publisher","first-page":"8908","DOI":"10.18632\/aging.205005","volume":"15","author":"Q Li","year":"2023","unstructured":"Li Q, Wei K, Zhang X, Lv Y, Li M, Zhou C, et al. TIMP1 shapes an immunosuppressive microenvironment by regulating anoikis to promote the progression of clear cell renal cell carcinoma. Aging. 2023;15(17):8908\u201329.","journal-title":"Aging"},{"key":"8446_CR99","doi-asserted-by":"publisher","first-page":"144223","DOI":"10.1016\/j.gene.2019.144223","volume":"726","author":"SF Khan","year":"2020","unstructured":"Khan SF, Damerell V, Omar R, Du Toit M, Khan M, Maranyane HM, et al. The roles and regulation of TBX3 in development and disease. Gene. 2020;726:144223.","journal-title":"Gene"},{"key":"8446_CR100","doi-asserted-by":"publisher","first-page":"113774","DOI":"10.1016\/j.biopha.2022.113774","volume":"155","author":"M Hashemi","year":"2022","unstructured":"Hashemi M, Arani HZ, Orouei S, Fallah S, Ghorbani A, Khaledabadi M, et al. EMT mechanism in breast cancer metastasis and drug resistance: Revisiting molecular interactions and biological functions. Biomed Pharmacother. 2022;155:113774.","journal-title":"Biomed Pharmacother"},{"issue":"2","key":"8446_CR101","doi-asserted-by":"publisher","first-page":"102611","DOI":"10.1016\/j.xcrm.2026.102611","volume":"7","author":"XL Peng","year":"2026","unstructured":"Peng XL, McCabe IC, Kharitonova EV, Xu Y, Zhao RT, Luan C, et al. DeCAF defines clinical fibroblast subtypes and multidimensional tumor-stroma crosstalk shaping prognosis and immunotherapy response. Cell Rep Med. 2026;7(2):102611.","journal-title":"Cell Rep Med"}],"container-title":["Journal of Translational Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12967-026-08446-x","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12967-026-08446-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T01:02:39Z","timestamp":1789002159000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12967-026-08446-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":101,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["8446"],"URL":"https:\/\/doi.org\/10.1186\/s12967-026-08446-x","relation":{},"ISSN":["1479-5876"],"issn-type":[{"value":"1479-5876","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"22 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"5 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"Not applicable.","order":1,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"1165"}}